4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-20-026296
Director disposed of 414,816 shares (other)
- Director acquired 99,324 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2020-09-22 | Other disposition | −328,324 | 1,746,493 | I | ||
| Bolzon Bradley J PhD Director | 2020-09-22 | Other acquisition | +84,544 | 84,544 | I | ||
| Bolzon Bradley J PhD Director | 2020-09-22 | Other disposition | −84,544 | 0 | I | ||
| Bolzon Bradley J PhD Director | 2020-09-22 | Other disposition | −1,948 | 10,355 | I | ||
| Bolzon Bradley J PhD Director | 2020-09-22 | Other acquisition | +14,780 | 22,171 | D |
Loading xslF345X03/doc4.xml…